Back to School: How biopharma can reboot drug development. Access exclusive analysis here

EchoGen-enhanced ultrasound contrast data

A Phase III trial using the SNUS ultrasound contrast agent, reported at the Chicago meeting of

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE